• Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular Contracture

  NCT05017337

  Unknown statusObservationalUpdated Jan 19, 2023
• Breast Cancer Index (BCI) Registry

  NCT04875351

  Active, not recruitingObservationalUpdated Sep 19, 2024
• Establishing an Inflammatory Breast Cancer Registry

  NCT00340158

  CompletedObservationalUpdated Apr 23, 2010
• ILR to Prevent BRCL_MCC 23608

  NCT07127003

  RecruitingInterventionalNot ApplicableUpdated Apr 30, 2026
• CairnSurgical Breast Cancer Locator (BCL) Post-Market Study

  NCT06461663

  CompletedInterventionalNot ApplicableUpdated May 27, 2026
• Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  NCT00477100

  RecruitingObservationalUpdated Apr 15, 2026

ClinicalTrials.gov ID

NCT04220970

Lead Sponsor

The Lymphoma Academic Research OrganisationOTHER

Overall Status

Recruiting

Study Type

Observational

Enrollment

150Estimated

Last Update Posted

Jan 14, 2026Actual

Start Date

Jun 7, 2017Actual

Primary Completion Date

Jun 7, 2032Estimated

Completion Date

Jun 7, 2032Estimated

Official Title

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Brief Summary

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.

Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).

This registry is opened in France and in Belgium

• Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

• BIA-ALCL

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

Female

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Adult patients with an anaplastic large cell lymphoma associated with breast implants

Exclusion Criteria:

-

Observational Model

Cohort

Time Perspective

Other

Lead Sponsor

The Lymphoma Academic Research OrganisationOTHER

benedicte.deau-fischer@cch.aphp.fr+33(0)158412132

marcela.anitei@ch-pau.fr05 59 72 67 96